ABOUT COMPANY
Precigen, Inc. discovers and develops the next generation of cell and gene therapies in the United States. The company is headquartered in Germantown, Maryland.
|
EARNINGS
Gross Profit (TTM): 6021000
Market Capitalization: 750459000
Operating Margin (TTM): -0.95
PE Ratio: None
PEG Ratio: 0
Profit Margin: -1.099
Revenue Per Share (TTM): 0.514
Revenue (TTM): 98985000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: -0.086
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.565
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: None
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|